Evidence-based clinical practice guidelines for chronic pancreatitis 2015

Journal of Gastroenterology

Volumn 51, Issue 2, 2016, Pages 85-92

  Ito, Tetsuhide ^a   Ishiguro, Hiroshi ^a   Ohara, Hirotaka ^a   Kamisawa, Terumi ^a   Sakagami, Junichi ^a   Sata, Naohiro ^a   Takeyama, Yoshifumi ^a   Hirota, Morihisa ^a   Miyakawa, Hiroyuki ^a   Igarashi, Hisato ^a   Lee, Lingaku ^a   Fujiyama, Takashi ^a   Hijioka, Masayuki ^a   Ueda, Keijiro ^a   Tachibana, Yuichi ^a   Sogame, Yoshio ^a   Yasuda, Hiroaki ^a   Kato, Ryusuke ^a   Kataoka, Keisho ^a   Shiratori, Keiko ^a   Sugiyama, Masanori ^a   Okazaki, Kazuichi ^a   Kawa, Shigeyuki ^a   Tando, Yusuke ^a   Kinoshita, Yoshikazu ^a   Watanabe, Mamoru ^a   Shimosegawa, Tooru ^a   more..

^a the Japanese Society of Gastroenterology (JSGE)   (Japan)

Author keywords

Chronis pancreatitis; Early stage chronic pancreatitis; GRADE system; Guidelines; Medical conservative therapy; Pain management; Pancreatic dysfunction; Pancreatic endocrine; Pancreatic exocrine; Surgical therapy

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

ANALGESIA; ASCITES; CHOLESTASIS; CHRONIC PANCREATITIS; DIET THERAPY; DRINKING BEHAVIOR; EVIDENCE BASED PRACTICE; EXTRACORPOREAL LITHOTRIPSY; HEALTH INSURANCE; HUMAN; LIFESTYLE MODIFICATION; PANCREAS ABSCESS; PANCREAS FISTULA; PANCREAS PSEUDOCYST; PANCREATIC ASCITES; PLEURA EFFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING CESSATION; STAGING; EVIDENCE BASED MEDICINE; JAPAN; PANCREATITIS, CHRONIC; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

EVIDENCE-BASED MEDICINE; HUMANS; JAPAN; PAIN MANAGEMENT; PANCREATITIS, CHRONIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84957426317     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1149-x     Document Type: Review

References (81)

1. Shimosegawa T, Kataoka K, Kamisawa T, et al. The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol. 2010;45:584–91.
2. Schünemann HJ, Oxman AD, Brozek J, et al. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid Based Med. 2008;13:162–3.
3. Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–10.
4. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
5. Pezzilli R, Talamini G, Gullo L. Behavior of serum pancreatic enzymes in chronic pancreatitis. Dig Liver Dis. 2000;32:233–7.
6. Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion. 1983;28:114–21.
7. Ammann RW, Muench R, Otto R, et al. Evolution and regression of pancreatic calcification in chronic pancreatitis: a prospective long-term study of 107 patients. Gastroenterology. 1988;95:1018–28.
8. Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with 8 conventional ultrasonography, computed tomography, and ERCP. Pancreas. 1995;10:251–7.
9. Rosch T, Schusdziarra V, Born P, et al. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease. Am J Gastroenterol. 2000;95:2261–70.
10. Bozkurt T, Braun U, Leferink S, et al. Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut. 1994;35:1132–6.
11. Sanyal R, Stevens T, Novak E, et al. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine function. AJR Am J Roentgenol. 2012;198:124–32.
12. Catalano MF, Lahoti S, Geenen JE, et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 1998;48:11–7.
13. Wiersema MJ, Hawes RH, Lehman GA, et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy. 1993;25:555–64.
14. Buscail L, Escourrou J, Moreau J, et al. Endoscopic ultrasonography in chronic pancreatitis: a comparative prospective study with conventional ultrasonography, computed tomography, and ERCP. Pancreas. 1995;10:251–7.
15. Mikata R, Ishihara T, Tada M, et al. Clinical usefulness of repeated pancreatic juice cytology via endoscopic naso-pancreatic drainage tube in patients with pancreatic cancer. J Gastroenterol. 2013;48:866–73.
16. Kataoka K, Yamane Y, Kato M, et al. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function: comparison to duodenal intubation tests. Pancreas. 1997;15:409–15.
17. Stasi MD, Lencioni R, Solmi L, et al. Ultrasound-guided fine needle biopsy of pancreatic masses: results of a multicenter study. Am J Gastroenterol. 1998;93:1329–33.
18. Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36–40.
19. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guideline for indication, counseling, consent and privacy issues. Pancreatology. 2001;1:405–15.
20. Teich N, Mossner J. Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2008;22:115–30.
21. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas. 1997;14:215–21.
22. Ramesh H. Proposal for a new grading system for chronic pancreatitis. J Clin Gastroenterol. 2002;35:67–70.
23. Ventrucci M, Gullo L, Daniele C, et al. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease. Digestion. 1983;28:114–21.
24. Kamisawa T, Matsukawa M, Yoshiike M, et al. Chronic pancreatitis progressing from segmental lesions. Hepatogastroenterology. 2005;52:1255–8.
25. Otsuki M. Chronic pancreatitis: the problems of diagnostic criteria. Pancreatology. 2004;4:28–41.
26. Catalano MF, Sahai A, Levy M, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69:1251–61.
27. Kitagawa M, Naruse S, Ishiguro H, et al. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas. 1997;15:402–8.
28. Kataoka K, Yamane Y, Kato M, et al. Diagnosis of chronic pancreatitis using noninvasive tests of exocrine pancreatic function: comparison to duodenal intubation tests. Pancreas. 1997;15:409–15.
29. Hayakawa T, Kondo T, Shibata T. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol. 1992;87:1170–4.
30. Koizumi M, Yoshida Y, Abe N, et al. Pancreatic diabetes in Japan. Pancreas. 1998;16:385–91.
31. Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Scand J Gastroenterol. 1994;29:949–60.
32. Schneider A, Löhr JM, Singer MV. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol. 2007;42:101–19.
33. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707.
34. Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984;25:1107–12.
35. Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly. 2006;136:166–74.
36. Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas. 1998;16:329–36.
37. Marotta F, O’Keefe SJ, Marks IN, et al. Pancreatic enzyme replacement therapy: importance of gastric acid secretion, H2-antagonists, and enteric coating. Dig Dis Sci. 1989;34:456–61.
38. Lankisch PG. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis. Digestion. 1993;54(Suppl 2):21–9.
39. Layer P, Keller J, Lankisch PG. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep. 2001;3:101–8.
40. Nakamura T, Arai Y, Tando Y, et al. Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis. Clin Ther. 1995;17:448–59.
41. Lankisch PG. Acute and chronic pancreatitis: an update on management. Drugs. 1984;28:554–64.
42. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in patients with acute and chronic pancreatitis. Gastroenterol Clin North Am. 1999;28:695–707.
43. Perry RS, Gallagher J. Management of maldigestion associated with pancreatic insufficiency. Clin Pharm. 1985;4:161–9.
44. Kawabe K, Ito T, Igarashi H, et al. The current managements of pancreatic diabetes in Japan. Clin J Gastroenterol. 2009;2:1–8.
45. Ito T, Otsuki M, Igarashi H, et al. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas. 2010;39:829–35.
46. Daniel JD, Michael AN. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1969–75.
47. Elashoff M, Matveyenko AV, Gier B, et al. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011;141:150–6.
48. Butler PC, Elashoff M, Elahoff R, et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care. 2013;36:2118–25.
49. Dore DD, Hussein M, Hoffman C, et al. A pooled analysis of exenatide use and risk of acute pancreatitis. Curr Med Res Opin. 2013;29:1577–86.
50. Nauck MA. A critical analysis of the clinical use of incretin-based therapies: the benefits by far outweigh the potential risks. Diabetes Care. 2013;36:2126–32.
51. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.
52. Varadarajulu S, Bang JY, Sutton BS, et al. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology. 2013;145:583–90.
53. Nealon WH, Walser E. Duct drainage alone is sufficient in the operative management of pancreatic pseudocyst in patients with chronic pancreatitis. Ann Surg. 2003;237:614–20.
54. Schlosser W, Siech M, Beger HG. Pseudocyst treatment in chronic pancreatitis: surgical treatment of the underlying disease increases the long-term success. Dig Surg. 2005;22:340–5.
55. Olakowski M, Mieczkowska-Palacz H, Olakowska E, et al. Surgical management of pancreaticopleural fistulas. Acta Chir Belg. 2009;109:735–40.
56. Tajima Y, Tsutsumi R, Kuroki T, et al. Evaluation and management of thoracopancreatic fistula. Surgery. 2006;140:773–8.
57. Ohge H, Yokoyama T, Kodama T, et al. Surgical approaches for pancreatic ascites: report of three cases. Surg Today. 1999;29:458–61.
58. Dumonceau JM, Tringali A, Blero D, et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–89.
59. Lermite E, Regenet N, Tuech JJ, et al. Diagnosis and treatment of hemosuccus pancreaticus: development of endovascular management. Pancreas. 2007;34:229–32.
60. Inui K, Tazuma S, Yamaguchi T, et al. Treatment of pancreatic stones with extracorporeal shock wave lithotripsy. Pancreas. 2005;30:26–30.
61. Ohara H, Hoshino M, Hayakawa T, et al. Single application extracorporeal shock wave lithotripsy is the first choice for patients with pancreatic duct stones. Am J Gastroenterol. 1996;91:1388–94.
62. Sauerbruch T, Holl J, Paumgartner G. Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut. 1992;33:969–72.
63. Hayakawa T, Kondo T, Shibata T, et al. Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Digestion. 1993;54:148–55.
64. Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Digestion. 1993;54:148–55.
65. Miyake H, Harada H, Kunichika K, et al. Clinical course and prognosis of chronic pancreatitis. Pancreas. 1987;2:378–85.
66. Andriulli A, Botteri E, Almasio PL, et al. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010;39:1205–10.
67. Cavallini G, Talamini G, Vaona B, et al. Effect of alcohol and smoking on pancreatic lithogenesis in the course of chronic pancreatitis. Pancreas. 1994;9:42–6.
68. Imoto M, DiMagno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas. 2000;21:115–9.
69. Kanoh M, Ibata H, Miyagawa M, et al. Clinical effects of camostat in chronic pancreatitis. Biomed Res. 1989;10(Suppl 1):145–50.
70. Cahen DL, Gouma DJ, Laramée P, et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology. 2011;141:1690–5.
71. Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2012;44:784–800.
72. Kataoka K, Sakagami J, Hirota M, et al. Effects of oral ingestion of the elemental diet in patients with painful chronic pancreatitis in the real-life setting in Japan. Pancreas. 2014;43:451–7.
73. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer: international Pancreatitis Study Group. N Engl J Med. 1993;328:1433–7.
74. Kamisawa T, Tu Y, Egawa N, et al. The incidence of pancreatic and extrapancreatic cancers in Japanese patients with chronic pancreatitis. Hepatogastroenterology. 2007;54:1579–81.
75. Capurso G, Falconi M, Panzuto F, et al. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. Am J Gastroenterol. 2009;104:3034–304.
76. Lankisch MR, Imoto M, Layer P, et al. The effect of small amounts of alcohol on the clinical course of chronic pancreatitis. Mayo Clin Proc. 2001;76:242–51.
77. Arvanitakis M, Van Laethem JL, Parma J, et al. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation. Endoscopy. 2004;36:535–42.
78. Löhr M, Müller P, Mora J, et al. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Gastrointest Endosc. 2001;53:734–43.
79. Nojgaard C, Bendtsen F, Becker U, et al. Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. Clin Gastroenterol Hepatol. 2010;8:384–90.
80. Lankisch PG, Löhr-Happe A, Otto J, et al. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 1993;54:148–55.
81. Knop FK, Vilsboll T, Larsen S, et al. No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis. Diabetes Care. 2003;26:2581–7.